Skip to main content
Erschienen in: Pediatric Rheumatology 1/2011

Open Access 01.12.2011 | Poster presentation

Aortoarteritis and cardiomyopathy in a child with Blau Syndrome

verfasst von: RP Khubchandani, RP Hasija, I Touitou, C Khemani

Erschienen in: Pediatric Rheumatology | Sonderheft 1/2011

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

Blau Syndrome, transmitted as an autosomal dominant condition, has been shown to have a novel mutation in the CARD15 (NOD2) locus. Cardiovascular features are rarely described in Blau Syndrome.

Aim

To report rare cardiovascular manifestations in a child with Blau Syndrome.

Method

Retrospective chart review of a child whom we first saw in 2002 and have been following up regularly since 2008.

Description

MG, now a 10 year old female, was seen with a history of recurrent fevers since 1 month of life with bilateral knee effusions noted at 1.5 years of age, in the year 2002. This was initially treated as ANA negative oligoarticular JIA, requiring intra-articular steroid injections twice. She has never had a history of skin manifestations or uveitis. Over time, the knees showed increasing bogginess without restriction of activity.
Six years after being lost to follow up, in mid 2008, at the age of 8 years, she presented with features of cardiac failure, arrhythmias (ventricular premature beats) and arthritis of the elbow joint. Investigations showed normal blood counts, normal eye examination and raised ESR. The 2D Echo showed dilated cardiomyopathy with a 20% ejection fraction with an abnormal myocardial echogenicity. Recurrent fevers since early childhood with arthritis and cardiomyopathy lead to a suspicion of an autoinflammatory syndrome. Further investigations showed a normal serum ACE and the DNA analysis showed a punctual mutation at G464W in exon 4 of the CARD15 gene. Liver and cardiac biopsies were deferred due to poor cardiac function. An identical genetic mutation was found in the mother who had a history of recurrent fevers, abdominal pain and respiratory symptoms that had never been investigated. Since then, MG has been on tapering oral steroid (started at 1mg/kg/day), injectable Methotrexate (15- 17.5 mg/m2) and anti-failure line of therapy. Initially, her symptoms improved with only a marginal improvement in the cardiac function. In early 2009, mild hypertension was documented and in September 2009, carotid pulsations were found reduced. By mid 2010, she had severe hypertension (230/120 mmHg), uncontrolled on multiple anti-hypertensives, with renal and carotid bruits. Digital Subtraction Angiography showed generalized narrowing of the aorta, carotids, left subclavian artery and bilateral renal arteries, suggestive of an aortoarteritis. The cerebral circulation was maintained normally with diffuse collaterals. The ultrasound abdomen showed a contracted left kidney with the right kidney perfusion maintained with an accessory artery with multiple renal hypo-echogenecities. The renal function and calcium excretion were normal with negative ANCAs. Three years into follow-up after diagnosis of aortoarteritis, on continuing therapy, she remains asymptomatic with an improvement in her cardiac function to an ejection fraction of 55%. Intervention such as stenting of the stenosed major vessels has currently been deferred due to the widespread nature of the aortoarteritis being aided with diffuse collateral circulation maintaining normal function.

Conclusions

In this child we never saw the classic triad of rash, arthritis and uveitis. Cardiomyopathy and aortoarteritis were the unusual manifestations which have been very rarely reported worldwide in Blau Syndrome patients.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Metadaten
Titel
Aortoarteritis and cardiomyopathy in a child with Blau Syndrome
verfasst von
RP Khubchandani
RP Hasija
I Touitou
C Khemani
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
Pediatric Rheumatology / Ausgabe Sonderheft 1/2011
Elektronische ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-9-S1-P36

Weitere Artikel der Sonderheft 1/2011

Pediatric Rheumatology 1/2011 Zur Ausgabe

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

13.05.2024 Assistierte Reproduktion Nachrichten

Reproduktionsmedizinische Techniken haben theoretisch das Potenzial, den epigenetischen Code zu verändern und somit das Krebsrisiko der Kinder zu erhöhen. Zwischen Embryotransfer und Leukämie scheint sich ein solcher Zusammenhang bestätigt zu haben.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.